Novel analogues of (+)-varitriol have been synthesised via Julia-Kocienski olefination from -Dribonolactone. Newly prepared compounds were screened for their in vitro cytotoxicity towards certain human tumours and NCI 60 cancer cell line panel.
Introduction
Marine fungi are an important source of marine natural products. The combination of potent biological properties and a relatively straightforward molecular structure of (+)-1 generated considerable synthetic interest directed toward the varitriol and its analogues. Since 2006, when Jennings et al. 4 established the absolute configuration of varitriol (+)-and (-)-varitriol have been reported. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] In addition, the furanoside and pyranoside analogues of (+)-varitriol have been synthesised, but only a few were evaluated for their antitumour activity.
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Figure 1. Chemical structures of the metabolites 1-4 from E. variecolor.
As a part of our ongoing project in the synthesis of new polyhydroxylated tetrahydrofurans as potential antitumour agents from monosaccharides, 15 we have recently developed a short and effective synthesis of varitriol from -D-ribonolactone. 7c Herein, we wish to report the synthesis of varitriol analogues and their antitumour activity.
Results and Discussion

Chemistry
The array of interesting biological properties of (+)-1 and the unknown mode of its action motivated us to synthesise a variety of analogues and to examine the bioactivity of structurally diverse "varitriol-like" compounds against set of tumour cell lines. New varitriol analogues have been designed by modification of the parent molecule (+)-1 by substitution in aromatic ring 6, configuration of furanoside part 5 as well as the geometry of the linker 7 ( Figure 2 ). All target compounds were prepared from -D-ribonolactone using our strategy for synthesis of (+)-varitriol. 7c The synthesis represents a short and efficient approach to (+)-1 in good overall yield (8 steps, 41% from D-ribonolactone and dimethylanisole). The key steps of the route include a highly stereoselective introduction of the methyl group at C-1 and Julia-Kocieński olefination with aromatic aldehyde at C-5 of the starting skeleton (Scheme 1). A rapid access to both key fragments, 8 and 9, as well as the late stage of convergence of the synthesis, make the strategy suitable for the synthesis of the large library of substances for investigation of structureactivity relationship (SAR).
tetrahydrofurans 13 and 14 were prepared in 94% overall yield. The diastereomers could be readily separated by preparative MPLC to provide 13 and 14 in 70% and 15% yield, respectively. The second crucial step of both syntheses, which were run in parallel with the pure diastereomers 13 (L-allo) and 14 (D-talo) is installation of the phenyltetrazole sulfide moiety. Firstly, silyl group was removed with tetrabutylammonium fluoride (2 equiv) in THF and alcohols 15 and 17 were exposed to Mitsunobu protocol for displacement of the primary hydroxyl group with phenyltetrazolylthiol. The reaction was carried out under standard reaction leading to the protected (+)-1 (6a), and with the set of commercially available aromatic aldehydes 9b-9k (Scheme 3). The couplings were performed under so-called Barbier reaction conditions. 20 The potassium hexamethyldisilazane (1.8 equiv) was added to the mixture of sulfone 8, and an excess amount of aldehyde 9 (5 equiv) in dimethoxyethane at -30 o C; the mixture was stirred at room temperature for 10 h. Final removal of the acetonide and acetyl protecting group with 1M aqueous HCl in THF and NaOMe in MeOH, respectively, furnished target compounds 6a-k, 7a-k as the mixtures of E/Z-isomers (Table 1) , which were separated by preparative MPLC.
Scheme 2. Reagents and conditions: (a)
TBDMSCl
Scheme 3.
Reagents and conditions: (a) KHDMS, DME, -30 o C to rt, 10 h; (b*) used for 6a, 7a: NaOMe, MeOH, rt, 4 h; (c) HCl, THF, rt, 3-12 h; see Table 1 . In the synthesis of 2-epi-varitriol 5, D-talo configurated sulfone 19 reacted with the corresponding aldehyde 9a under the same reaction conditions as above (Scheme 4). Global deprotection of all hydroxyl groups using the previously described conditions 7c gave 2-epivaritriol 5 as a mixture of E/Z-isomers in the ratio 5:4.
Scheme 4.
Reagents and conditions: (a) KHDMS, DME, -30 o C to rt, 10 h; (b) NaOMe, MeOH, rt, 4 h; HCl, THF, rt, 5 h, 78% overall yield (E/Z-mixture in the ratio 5:4).
In vitro cytotoxic activity
Compounds 5, 6 and 7 were evaluated for their in vitro cytotoxicity against human drug sensitive (CCRF-CEM, K562) versus multidrug resistant leukaemia cell lines (K562-Tax, CEM-DNR-BULK), colon cancer cells with normal (+/+) or inactive (-/-) p53 oncosuppressor (HCT116p53 +/+ , HCT116p53 -/-), lung adenocarcinoma (A549), normal foetal lung (MRC-5) and foreskin (BJ) fibroblasts. Cytotoxic activity was evaluated after 72 hrs of treatments using a cytotoxic MTT assay, based on reduction of yellow tetrazolium salt on blue formazan in mitochondria of living cellsM. The determined activities were expressed as IC 50 values (concentrations leading to 50% decrease in cell survival).
As outlined in Table 2 , compounds displayed only a mild activity against the above mentioned cell lines. The configurationally modified varitriol 5 as a mixture of E/Z-isomers (in the ratio 5:4) showed the most significant activities against the all tested cell lines, whereas varitriol 6a (E-isomer) and its Z-analogue 7a showed much lower activities or were inactive. Interestingly, the difference in the geometry of the linker 6a, 6h, 6k (E-isomers) vs 7a, 7h, 7k, caused in general a slightly higher cytotoxic activities of Z-isomers (7a, 7h, 7k) . The widest spectrum of activities from the set of analogues with differently substituted aromatic part, were displayed by compounds 6e (2,4-dimethoxy), 6f (2,5-dimethoxy), 6i (4-bromo 
Conclusions
In summary, the varitriol analogues with modified aromatic part 6a-k, geometry of the C-C double bond 7a-c, 7e,f, 7h and 7k, as well as a new 2-epimer 5 have been synthesised and evaluated for their in vitro antitumour activities against a number of selected human neoplastic cell lines and NCI 60 cancer cell line panel at the Developmental Therapeutics Program, National Cancer Institute. All the compounds showed only mild activity, and compound 5 was the most active among the screened compounds. Though the compounds showed mild activity, the synthesis and screening of more analogues of varitriol with higher structural diversity or synthesis and exploration of bioactivity the other compounds (varioxirane 2, dihydroterrein 3, and varixanthone 4) isolated from a marine-derived strain of the fungus Emericella variecolor, would give scope for further work in this area. Finally, the synthetic strategy has been proven to apply for rapid construction of varitriol analogues with variable side chain, linker and configuration of furanoside portion of the target molecule.
Experimental Section
General. Commercial reagents were used without further purification. All solvents were distilled before use. Hexanes refer to the fraction boiling at 60-65 o C. Flash column liquid chromatography (FLC) was performed on silica gel Kieselgel 60 (40-63 m, 230-400 mesh) using Buchi Sepacore® preparative MPLC system and analytical thin-layer chromatography (TLC) was performed on aluminum plates pre-coated with either 0. 
2,5-Anhydro-6-deoxy-3,4-O-isopropylidene-1-O-tertbutyldimethylsilyl-L-allitol (13) and 2,5-anhydro-6-deoxy-3,4-O-isopropylidene-1-O-tertbutyldimethylsilyl-D-talitol (14)
. The lactone 12 (1.9 g, 6.29 mmol) was dissolved in dry toluene (120 mL), cooled to -78 °C under argon atmosphere and 10% w/w solution of DIBAL in hexanes (13 mmol, 28 mL) was added dropwise. Reaction mixture was allowed to warm to -50 °C and after 4 h was quenched with HCl 3M, 10 mL). After warming to room temperature reaction was extracted between water (100 mL) and ether (3 x 30 mL), combined organic layers were washed with brine, dried over MgSO 4 and concentrated. The crude product was dissolved in dry dichloromethane (60 mL), cooled to 0 °C, than DMAP (2.3 g, 18.8 mmol) and Ac 2 O (1.2 ml, 12.6 mmol) were added and the mixture was stirred for 12 h. Resulting mixture was diluted with DCM (100 mL), washed with water (50 mL) and brine (50 mL), concentrated and used for subsequent methylation without further 
2,5-Anhydro-6-deoxy-3,4-O-isopropylidene-1-O-tertbutyldimethylsilyl-D-talitol (14).
2,5-Anhydro-6-deoxy-3,4-O-isopropylidene-L-allitol (15
General procedure for the preparation of varitriol analogues
The solution of sulfone (8 or 19, 1 equiv) and aldehyde (9, 5 equiv) in dry DME (10 mL/100 mg of sulfone) was cooled to -30 °C under argon atmosphere. Potassium hexamethyldisilazane (0.5 M in toluene, 1.6 equiv) was added dropwise and the resulting mixture was allowed to warm slowly to rt and stirred overnight. The reaction was then quenched by addition of water (0.5 mL) and concentrated in vacuo. The crude product of the olefination was dissolved in THF (20 mL/100 mg of sulfone) and 1M aqueous HCl (20 mL/100 mg of sulfone) was added. The reaction mixture was stirred at rt until full conversion (TLC control, 3-12h). Mixture was neutralised with solid Na 2 CO 3 and extracted with ethyl acetate. The combined organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude product was purified by flash chromatography on silica gel. Combined yields of olefins 5, 6, 7 as well as the yields of isolated pure isomers 6, 7 are given in the Table 1 . Deprotection of hydroxyl groups in the compounds 5, 6a, 7a was carried out as follows: the crude product was dissolved in MeOH (6 mL) and freshly prepared sodium methoxide (0.6 M in MeOH, 2.1 mL) was added. The mixture was allowed to stir for 4 h, by which time TLC (EtOAc/hexanes, 3:7) showed complete conversion of the starting material. The residue was dissolved in THF (20 mL) and 1M aqueous HCl (20 mL) and stirred at rt for 5 h. The work-up followed as above. 1. All cells were purchased from the American Tissue Culture Collection (ATCC), unless otherwise indicated: the CCRF-CEM line are highly chemosensitive T-lymphoblastic leukemia cells, K562 cells were derived from patient with acute myeloid leukemia with bcr-abl translocation, A549 line is lung adenocarcinoma, HCT116 is colorectal tumor cell line and its p53 gene knock-down counterpart (HCT116p53-/-, Horizon Discovery, UK) is a model of human cancers with p53 mutation frequently associated with poor prognosis. The daunorubicin resistant subline of CCRF-CEM cells (CEM-DNR bulk) and paclitaxel resistant subline K562-tax were selected in our laboratory by the cultivation of maternal cell lines in increasing concentrations of daunorubicine or paclitaxel, respectively. 22 The CEM-DNR bulk cells overexpress MRP-1 protein, while K562-tax cells overexpress P-glycoprotein, both proteins belong to family of ABC transporters and are involved in primary and/or acquired multidrug resistance phenomenon. 22 The cells were maintained in Nunc/Corning 80 cm 2 plastic tissue culture flasks and cultured in cell culture medium (DMEM/RPMI 1640 with 5 g/L glucose, 2 mM glutamine, 100 U/mL penicillin, 100 g/mL streptomycin, 10 % fetal calf serum, and NaHCO 3 ).
2-Epi-varitriol (5)
.
E-(2S,3R,4S,5R)-5-(2-Methoxystyryl)-2-methyltetrahydrofuran-3,4-diol (6c)
2.
Cell suspensions were prepared and diluted according to the particular cell type and the expected target cell density (2 500-30 000 cells/well based on cell growth characteristics). Cells were added by pipette (80 L) into 96-well microtiter plates. Inoculates were allowed a preincubation period of 24 h at 37 °C and 5 % CO 2 for stabilisation. Four-fold dilutions, in 20-L aliquots, of the intended test concentration were added to the microtiter plate wells at time zero. All test compound concentrations were examined in duplicate. Incubation of the cells with the test compounds lasted for 72 h at 37 °C, in a 5 % CO 2 atmosphere at 100 % humidity. At the end of the incubation period, the cells were assayed using MTT. Aliquots (10 L) of the MTT stock solution were pipetted into each well and incubated for a further 1-4 h. After this incubation period the formazan produced was dissolved by the addition of 100 L/well of 10 % aq SDS (pH = 5.5), followed by a further incubation at 37 °C overnight. The optical density (OD) was measured at 540 nm with a Labsystem iEMS Reader MF. Tumour cell survival (TCS) was
